Figure 3. Estimated ORs (95% CIs) for associations of fasting plasma sLOX‐1 (SD‐units) and cardiometabolic risk features, adjusted for age, sex, smoking status, and BMI SDS.

BMI indicates body mass index; high ALT, high alanine transaminase (surrogate measure of hepatic steatosis); OR, odds ratio; SDS, SD score; and sLOX‐1, soluble lectin‐like oxidized low‐density lipoprotein.